OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders. The Nuclear Mitome Test, employs next-generation sequencing technology to identify mutations in more than 400 genes, and represents the most comprehensive genetic test available for mitochondrial disorders. […]

VENLO, The Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. (Alternext: ALIPS) and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range […]

TUCSON, Ariz. – HTG Molecular Diagnostics, a provider of molecular technology solutions, today announced, SR One, the corporate venture capital arm of GlaxoSmithKline, joined the second tranche of its series D financing. The company has raised $16.2 million in this series D financing. SR One joins this round which was led by Novo A/S and […]

CINCINNATI – Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its tests detect the deadly toxins produced by the recent outbreak strain E. coli O104:H4. E. coli O104:H4 is the novel shiga toxin-producing strain associated with a number of deaths in Europe. It has also caused hemolytic uremic syndrome (HUS) (a type of kidney failure) in […]

NEW YORK – Enzo Biochem Inc. (NYSE:ENZ), as part of its continuing program to offer novel molecular tests, announced that its Enzo Clinical Labs subsidiary has reached an agreement with IncellDx Inc. of Menlo Park, CA, for the rights to market a proprietary laboratory test. The test is based upon HPV OncoTect™, an advanced molecular […]

Source BioScience (LSE: SBS), in partnership with Barts Cancer Institute and Illumina Inc., is collaborating to develop a novel approach to cancer diagnosis and personalised treatment for patients. The collaboration has won a grant of £0.5m through the Technology Strategy Board’s ‘Tumour Profiling and Data Capture to Improve Cancer Care’ funding competition. The aim is […]

WESTBOROUGH, Mass. – GenomeQuest Inc. today announced it has appointed Gerry A. Higgins, Ph.D., a nationally recognized scientist and pioneer in genomics research, as the company’s first Healthcare Innovation Officer. In his new role, Dr. Higgins will focus on applying the company’s proprietary technology to the development of whole genome and multi-gene diagnostics for the […]

POTOMAC FALLS, Va. – TessArae®, LLC, a privately held company, today announced that it has appointed Tom Richards as its new President. Dr. Richards has held faculty positions at Stanford University Medical Center and UCSF Medical Center, where he currently practices as an Assistant Clinical Professor in the Department of Emergency Medicine. Richards is a […]

AUSTIN, Texas and KOLN, Germany – Luminex Corporation (NASDAQ: LMNX) and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex’s newly released xTAG® Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli […]

TORONTO – SQI Diagnostics Inc. (the “Company”, “SQI Diagnostics” or “SQI”) (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has received notice that the United States Food and Drug Administration (FDA) has cleared the Company’s automated SQiDworks(TM) diagnostics platform and its […]